Loading patent…
AssigneeThe Regents of the University of California
InventorsJonathan T. Skare, Ellen S. Shang, Cheryl I. Champion, David R. Blanco, James N. Miller, Michael A. Lovett, Tajib A. Mirzabekov, Bruce L. Kagan, Paul Tempst, Denise M. Foley
Estimating the term…
The present invention presents three B. burgdorferi membrane proteins: Oms28, Oms45, and Oms66, each of about 28, 45, and 66 kDa respectively; and with average single channel conductances of about 0.6, 0.22, and 9.7 nS, respectively. Also disclosed are the methods for purifying these proteins from B. burgdorferi, methods for producing antibodies to these proteins, and the resulting antibodies. These proteins and their immunogenic fragments, and antibodies capable of binding to them are useful for inducing an immune response to pathogenic B. burgdorferi as well as providing a diagnostic target for Lyme disease. Further disclosed are the nucleotide and amino acid sequences, the cloning of the genes encoding the proteins and their recombinant proteins, and methods for obtaining the foregoing. Other B. burgdorferi outer membrane spanning proteins (Oms) obtainable by the isolation and purification methods of the present invention.
An outer membrane spanning protein isolated from Borrelia outer membrane comprising Oms28.
A purified protein consisting essentially of Oms28.
An amino acid sequence of Oms28.
A pharmaceutical composition comprising an immunogenically effective amount of Oms28.
A method of producing antibodies which recognize Borrelia burgdorferi comprising administering to a host an immunogenically effective amount of Osm28.
Dependencies are inferred from the claim text.